Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-01-28 @ 4:47 PM
Study NCT ID:
NCT05770102
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2023-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
Sponsor:
Cancer Research UK
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2029-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-22
First Submit QC Date:
None
Study First Post Date:
2023-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-19
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED